CSPC operates in a fast-growing and rapidly changing environment. Like most healthcare sectors in China, drug manufacturing has grown faster than GDP, and is projected to continue this trend over ...
Hosted on MSN8mon
Moderna rival CSPC cleared to study RSV shot in ChinaShijiazhuang-based CSPC (OTCPK:CHJTF) said that SYS6016 has already undergone preclinical trials, neutralizing both RSV-A and RSV-B strains of the virus with a favorable safety profile.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback